Here are what the editors at HealthDay consider to be the most important developments in Allergy for March 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Vertical Integration Insurance Products of Higher Quality
FRIDAY, March 31, 2017 (HealthDay News) -- Insurance products offered by hospitals and health systems, known as vertical integration, are generally of higher quality than other contracts, according to a study published in the March issue of Health Affairs.
Abstract
Full Text (subscription or payment may be required)
90 Percent of U.S. Physicians Satisfied With Career Choice
FRIDAY, March 31, 2017 (HealthDay News) -- Nine out of 10 American doctors are happy with their choice of profession, even though they have some challenges, according to an American Medical Association (AMA) survey of 1,200 doctors, residents, and medical students, conducted in February.
More Information
FDA Approves Dupixent to Treat Eczema
WEDNESDAY, March 29, 2017 (HealthDay News) -- Dupixent (dupilumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe eczema that isn't well controlled by topical medication.
More Information
TV Ads for ACA Enrollment Linked to Decline in Uninsured Rates
TUESDAY, March 28, 2017 (HealthDay News) -- The volume of insurance advertisements during the first Affordable Care Act enrollment period correlated with change in uninsurance rates, with a higher volume of television advertisements linked to declines in uninsurance, according to a study published online March 15 in Health Affairs.
Abstract
Full Text (subscription or payment may be required)
ACP Issues Challenge to Cut Task Burden and Put Patients First
TUESDAY, March 28, 2017 (HealthDay News) -- In a position paper published online March 28 in the Annals of Internal Medicine, recommendations are presented to address the impact of administrative tasks and reduce the administrative burden on clinicians.
Abstract/Full Text
Editorial (subscription or payment may be required)
Paid Malpractice Claims Cut in Half From 1992 to 2014 in U.S.
MONDAY, March 27, 2017 (HealthDay News) -- From 1992 to 2014 there was a decrease in the rate of malpractice claims paid on behalf of physicians in the United States, but mean compensation amounts increased, according to a study published online March 27 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
30-Day Mortality Down During Joint Commission Survey Weeks
THURSDAY, March 23, 2017 (HealthDay News) -- Patients admitted to the hospital during The Joint Commission on-site inspections (surveys) have reduced mortality compared to that seen during non-survey weeks, according to research published online March 20 in JAMA Internal Medicine.
Abstract/Full Text
C1 Inhibitor Use Reduces Attacks in Hereditary Angioedema
THURSDAY, March 23, 2017 (HealthDay News) -- Prophylactic use of the subcutaneous C1 inhibitor CSL830 is associated with a reduction in the frequency of acute attacks in patients with hereditary angioedema, according to a study published in the March 23 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Black, Asian Medical Students Less Likely to Be AΩA Members
TUESDAY, March 21, 2017 (HealthDay News) -- Black and Asian medical students are less likely to be members of the Alpha Omega Alpha (AΩA) honor society than white students, according to a study published online March 6 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Phthalate, Paraben Levels Up in Children With Atopic Dermatitis
TUESDAY, March 21, 2017 (HealthDay News) -- Children aged 4 to 9 years with atopic dermatitis and with frequent use of emollients have increased urinary levels of low-molecular weight (LMW) phthalate metabolites and parabens, according to a study published online March 9 in Allergy.
Abstract
Full Text (subscription or payment may be required)
Los Angeles eConsult Program Can Reduce Wait Times
FRIDAY, March 17, 2017 (HealthDay News) -- Implementation of an electronic system for provision of specialty care was rapidly adopted in Los Angeles, and it can reduce wait times to see specialists, according to a study published in the March issue of Health Affairs.
Abstract
Full Text (subscription or payment may be required)
Supervised Self-Injection Ups Teens' Comfort With Approach
THURSDAY, March 16, 2017 (HealthDay News) -- For food-allergic adolescents at risk for anaphylaxis, supervised self-infection with an empty syringe is associated with improved comfort levels with self-injection, according to a study published in the March-April issue of the Journal of Allergy and Clinical Immunology: In Practice.
Abstract
Full Text (subscription or payment may be required)
Women Underrepresented Among Grand Rounds Speakers
WEDNESDAY, March 15, 2017 (HealthDay News) -- Women seem to be underrepresented among academic grand rounds (GR) speakers, according to a research letter published online March 6 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Support for Health Law Up to 48 Percent in February
TUESDAY, March 14, 2017 (HealthDay News) -- Support for the health law is increasing, with most Americans feeling that Medicaid should continue as it is today, according to a report published by Kaiser Health News.
More Information
Mite-Proof Mattress Covers Could Reduce Severity of Asthma Flares
MONDAY, March 13, 2017 (HealthDay News) -- Children with asthma have fewer severe exacerbations when their beds have mite-proof covers, according to a study published online March 10 in the American Journal of Respiratory and Critical Care Medicine.
Abstract
Full Text (subscription or payment may be required)
Skin Prick, sIgE Have Moderate Agreement for Allergic Disease
MONDAY, March 13, 2017 (HealthDay News) -- For 10-year-old children, skin prick test (SPT) and specific immunoglobulin E (sIgE) have moderate agreement for allergic diseases, according to a study published online Feb. 24 in Allergy.
Abstract
Full Text (subscription or payment may be required)
ACA's Medicaid Expansion May Pose Challenges to Timely Care
THURSDAY, March 9, 2017 (HealthDay News) -- People living in states that expanded Medicaid under the Affordable Care Act (ACA) are less likely to be uninsured or struggling with the strain of unpaid medical bills, but they also seem to have increased difficulty receiving timely care, according to research published in the March 9 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Republicans Introduce Affordable Care Act Replacement
TUESDAY, March 7, 2017 (HealthDay News) -- An initial Republican replacement for the Affordable Care Act was formally introduced in the House of Representatives on Monday.
More Information
Most Health Care Providers Can Offer Cost Estimate
MONDAY, March 6, 2017 (HealthDay News) -- Most provider organizations can offer a cost estimate, although few patients request one, according to a report published by Becker's Hospital CFO.
More Information
Tolerance Develops in NSAID-Induced Urticaria/Angioedema
FRIDAY, March 3, 2017 (HealthDay News) -- Patients with nonsteroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema (NIUA) may develop tolerance to NSAIDs over time, according to a study published online Feb. 22 in Allergy.
Abstract
Full Text (subscription or payment may be required)
Judgement Bias in Medical Device Recall Decisions
FRIDAY, March 3, 2017 (HealthDay News) -- The characteristics of the signal in user feedback of adverse events associated with medical devices and the situated context of decision makers correlate with judgement bias in reacting to these adverse events, according to research published online Jan. 29 in Production and Operations Management.
Abstract
Full Text (subscription or payment may be required)
FDA Approves Odactra for House Dust Mite Allergies
FRIDAY, March 3, 2017 (HealthDay News) -- A new treatment for dust mite allergies has been approved by the U.S. Food and Drug Administration.
More Information
Nemolizumab Found to Be Effective in Atopic Dermatitis
FRIDAY, March 3, 2017 (HealthDay News) -- An experimental drug, nemolizumab, may significantly reduce the itching and improve the appearance of moderate-to-severe atopic dermatitis, according to a study published in the March 2 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Overall, 8.8 Percent of U.S. Population Uninsured in 2016
THURSDAY, March 2, 2017 (HealthDay News) -- Overall, 8.8 percent of individuals of all ages were uninsured in the first nine months of 2016, which marked a nonsignificant reduction from 2015, according to a Feb. 14 report from the National Center for Health Statistics.
Full Text
